While the United States takes a bit of a Thanksgiving breather this week, trade officials in Geneva and Brussels have a full plate of issues to deal with as the World Trade Organization tries to figure out whether to move forward with an intellectual property waiver for COVID-19 diagnostics and therapeutics while EU officials discuss Europe’s trade ties with the United States, as well as the bloc’s increasingly complicated relationship with China.

Health care can benefit from the streamlined FDA authorization processes used during the pandemic, former FDA Principal Deputy Commissioner Amy Abernethy said, but the agency needs to do a better job collecting postmarket data and communicating with the public.